Ironwood Pharmaceuticals

Ironwood Pharmaceuticals is a biotechnology company utilizing its development and commercial capabilities as it brings various medicines to patients. The company's commercial product, linaclotide, is available to adult men and women suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation in certain countries. The company is developing another gastrointestinal development program, IW-3718, a gastric retentive formulation of a bile acid sequestrant for the potential treatment of uncontrolled gastroesophageal reflux disease. The company is commercializing in the U.S. two products within its uncontrolled gout program, DUZALLO? (lesinurad and allopurinol) and ZURAMPIC? (lesinurad).
  • TickerIRWD
  • ISINUS46333X1081
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

David Nierengarten ...
  • Jeffrey La Rosa

Retail Prescription Sales Tracker - Constipation Drugs

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Robert Driscoll

Recent Drug Launch Weekly Retail Sales Tracker - Week Ended May 10

David Nierengarten ...
  • Jeffrey La Rosa

Retail Prescription Sales Tracker - Constipation Drugs

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Robert Driscoll

Recent Drug Launch Weekly Retail Sales Tracker - Week Ended May 10

David Nierengarten ...
  • Jeffrey La Rosa

Retail Prescription Sales Tracker - Constipation Drugs

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

MarketLine Department

Ironwood Pharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary Pharmaceuticals and Healthcare Key Findings Pharmaceuticals and Healthcare Pharmaceuticals and Healthcare Reasons To Buys MarketLine Key Highlights United States

Dave Nicoski ...
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch